SI1173440T1 - Tetracyclic azepinoindole compounds as 5-ht receptor ligands - Google Patents

Tetracyclic azepinoindole compounds as 5-ht receptor ligands

Info

Publication number: SI1173440T1
Authority: SI; Slovenia
Prior art keywords: azepinoindole; tetracyclic; compounds; receptor ligands; ligands
Prior art date: 1999-04-23

Application number

SI200030516T

Other languages

English (en)

Slovenian (sl)

Inventor

Jackson B. Hester Jr.

Bruce N. Rogers

E. Jon Jacobsen

Michael Dalton Ennis

Brad A. Acker

Velde Susan L. Vander

Kristine E. Frank

Original Assignee

Pharmacia & Upjohn Company

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-23

Filing date

2000-04-20

Publication date

2005-02-28

2000-04-20 Application filed by Pharmacia & Upjohn Company filed Critical Pharmacia & Upjohn Company

2005-02-28 Publication of SI1173440T1 publication Critical patent/SI1173440T1/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/16—Peri-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/16—Peri-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Reproductive Health (AREA)
Psychiatry (AREA)
Endocrinology (AREA)
Psychology (AREA)
Hospice & Palliative Care (AREA)
Obesity (AREA)
Diabetes (AREA)
Gynecology & Obstetrics (AREA)
Child & Adolescent Psychology (AREA)
Addiction (AREA)
Hematology (AREA)
Otolaryngology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

SI200030516T 1999-04-23 2000-04-20 Tetracyclic azepinoindole compounds as 5-ht receptor ligands SI1173440T1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US13081199P	1999-04-23	1999-04-23
PCT/US2000/010600 WO2000064899A1 (en)	1999-04-23	2000-04-20	Tetracyclic azepinoindole compounds as 5-ht receptor ligands
EP00923532A EP1173440B1 (en)	1999-04-23	2000-04-20	Tetracyclic azepinoindole compounds as 5-ht receptor ligands

Publications (1)

Publication Number	Publication Date
SI1173440T1 true SI1173440T1 (en)	2005-02-28

Family

ID=22446459

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200030516T SI1173440T1 (en)	1999-04-23	2000-04-20	Tetracyclic azepinoindole compounds as 5-ht receptor ligands

Country Status (20)

Country	Link
EP (1)	EP1173440B1 (es)
JP (1)	JP2002543080A (es)
KR (1)	KR20020005708A (es)
CN (1)	CN1183132C (es)
AR (1)	AR023574A1 (es)
AT (1)	ATE276255T1 (es)
AU (1)	AU760943C (es)
BR (1)	BR0009983A (es)
CA (1)	CA2367682A1 (es)
DE (1)	DE60013803T2 (es)
DK (1)	DK1173440T3 (es)
EC (1)	ECSP003426A (es)
ES (1)	ES2226822T3 (es)
HK (1)	HK1045512B (es)
NZ (1)	NZ514553A (es)
PE (1)	PE20010052A1 (es)
PT (1)	PT1173440E (es)
SI (1)	SI1173440T1 (es)
WO (1)	WO2000064899A1 (es)
ZA (1)	ZA200108636B (es)

Families Citing this family (67)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HK1043112A1 (zh)	1999-06-15	2002-09-06	Bristol-Myers Squibb Pharma Company	取代的稠杂环γ-咔啉
US6713471B1 (en)	1999-06-15	2004-03-30	Bristol-Myers Squibb Pharma Company	Substituted heterocycle fused gamma-carbolines
US7071186B2 (en)	1999-06-15	2006-07-04	Bristol-Myers Squibb Pharma Co.	Substituted heterocycle fused gamma-carbolines
WO2002004456A1 (en)	2000-07-06	2002-01-17	Pharmacia & Upjohn Company	SUBSTITUTED 2,3,7,8,9,10,11,12-OCTAHYDROAZEPINO[4,5-b]PYRANO[3,2-e]INDOLES
AR035493A1 (es)	2000-09-20	2004-06-02	Upjohn Co	Derivados de azepino (4,5b) indolina sustituidos, composicion farmaceutica y el uso de dichos derivados para preparar un medicamento
AR031200A1 (es)	2000-11-03	2003-09-10	Wyeth Corp	Cicloocta [b] [1,4] diazepino [6,7,1-hi] indoles y derivados
AR031199A1 (es)	2000-11-03	2003-09-10	Wyeth Corp	Ciclohepta/b//1,4/diacepino/6,7,1-hi/indoles y derivados
AR031202A1 (es)	2000-11-03	2003-09-10	Wyeth Corp	Ciclopenta(b) (1,4)diazepino(6,7,1-hi) indoles y derivados
US6849619B2 (en)	2000-12-20	2005-02-01	Bristol-Myers Squibb Company	Substituted pyridoindoles as serotonin agonists and antagonists
HUP0303432A3 (en)	2000-12-20	2012-09-28	Bristol Myers Squibb Co	Substituted pyridoindoles as serotonin agonists and antagonists and pharmaceutical compositions containing the compounds and their use
US20020160999A1 (en) *	2001-01-08	2002-10-31	Jacobsen Susan Fox	Substituted indolines
US20030060462A1 (en) *	2001-08-06	2003-03-27	Hoffman Robert L.	Therapeutic compounds
BR0211559A (pt) *	2001-08-06	2004-07-13	Upjohn Co	Compostos, composições de ligantes tetracìclicos terapeuticamente úteis e seus usos
EP1429776A2 (en) *	2001-09-21	2004-06-23	PHARMACIA & UPJOHN COMPANY	Tricyclic indole derivatives as 5-ht ligands
CA2464412A1 (en) *	2001-10-18	2003-04-24	Pharmacia & Upjohn Company	Tetracyclic azaindoles and -indolines having serotonin 5-ht2cactivity
TWI312781B (en)	2002-04-25	2009-08-01		[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
TW200307540A (en)	2002-04-25	2003-12-16	Wyeth Corp	[1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents
TW200307682A (en)	2002-04-25	2003-12-16	Wyeth Corp	1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents
WO2006022420A1 (ja)	2004-08-25	2006-03-02	Takeda Pharmaceutical Company Limited	腹圧性尿失禁の予防・治療剤及びそのスクリーニング方法
GT200500317A (es)	2004-11-05	2006-10-27		Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos
AR054849A1 (es)	2005-07-26	2007-07-18	Wyeth Corp	Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas
NZ569554A (en) *	2006-01-19	2011-10-28	Athersys Inc	Thiophenyl and pyrrolyl azepines as serotonin 5-HT2C receptor ligands and uses thereof
JP5528699B2 (ja)	2006-05-16	2014-06-25	武田薬品工業株式会社	縮合複素環化合物およびその用途
KR101805914B1 (ko)	2007-03-12	2017-12-06	인트라-셀룰라 써래피스, 인코퍼레이티드.	치환된 헤테로환 융합 감마-카르볼린 합성
JP5520051B2 (ja)	2007-11-15	2014-06-11	武田薬品工業株式会社	縮合ピリジン誘導体およびその用途
KR101614723B1 (ko)	2008-01-11	2016-04-22	알바니 몰레큘라 리써치, 인크.	Ｍｃｈ 길항물질로서 (1-아지논)-치환된 피리도인돌
WO2010124042A2 (en) *	2009-04-23	2010-10-28	Abbott Laboratories	Modulators of 5-ht receptors and methods of use thereof
US8629158B2 (en)	2009-07-01	2014-01-14	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
JP2012532144A (ja)	2009-07-01	2012-12-13	アルバニーモレキュラーリサーチ，インコーポレイテッド	アジノン置換アゼピノ［ｂ］インドールおよびピリド−ピロロ−アゼピンｍｃｈ−１拮抗薬、ならびにその作製方法および使用
US8618299B2 (en)	2009-07-01	2013-12-31	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle MCH-1 antagonists, methods of making, and use thereof
EP2510949A4 (en)	2009-12-11	2013-11-13	Astellas Pharma Inc	THERAPEUTICS FOR FIBROMYALGIA
US8697700B2 (en)	2010-12-21	2014-04-15	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof
US8993765B2 (en)	2010-12-21	2015-03-31	Albany Molecular Research, Inc.	Tetrahydro-azacarboline MCH-1 antagonists, methods of making, and uses thereof
AU2013245702A1 (en)	2012-04-14	2014-11-13	Intra-Cellular Therapies, Inc.	Organic compounds
WO2014145192A1 (en)	2013-03-15	2014-09-18	Intra-Cellular Therapies, Inc.	Organic compounds
WO2015085004A1 (en)	2013-12-03	2015-06-11	Intra-Cellular Therapies, Inc.	Novel methods
CA2944755A1 (en)	2014-04-04	2015-10-08	Intra-Cellular Therapies, Inc.	Organic compounds
KR20170012210A (ko)	2014-04-04	2017-02-02	인트라-셀룰라 써래피스, 인코퍼레이티드.	유기 화합물
PL3838274T3 (pl)	2016-01-26	2024-04-02	Intra-Cellular Therapies, Inc.	Pochodna pirydo[3',4':4,5]pirolo[1,2,3-DE]chinoksaliny do zastosowania w leczeniu zaburzeń OUN
JP2019513143A (ja)	2016-03-28	2019-05-23	イントラ−セルラー・セラピーズ・インコーポレイテッドＩｎｔｒａ−ＣｅｌｌｕｌａｒＴｈｅｒａｐｉｅｓ，Ｉｎｃ．	新規塩類および結晶
US11014925B2 (en)	2016-03-28	2021-05-25	Intra-Cellular Therapies, Inc.	Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide
US10682354B2 (en)	2016-03-28	2020-06-16	Intra-Cellular Therapies, Inc.	Compositions and methods
CN105837571A (zh) *	2016-04-23	2016-08-10	何华琼	盐酸倍他司汀的药物组合物及其在生物医药中的应用
EP3519816A4 (en)	2016-09-29	2020-05-06	The Regents of the University of California	Compounds for increasing neural plasticity
US11331316B2 (en)	2016-10-12	2022-05-17	Intra-Cellular Therapies, Inc.	Amorphous solid dispersions
WO2018126140A1 (en)	2016-12-29	2018-07-05	Intra-Cellular Therapies, Inc.	Organic compounds
WO2018126143A1 (en)	2016-12-29	2018-07-05	Intra-Cellular Therapies, Inc.	Organic compounds
WO2018175969A1 (en)	2017-03-24	2018-09-27	Intra-Cellular Therapies, Inc.	Novel compositions and methods
CA3071137A1 (en)	2017-07-26	2019-01-31	Intra-Cellular Therapies, Inc.	Prodrugs of substituted heterocycle fused gamma-carbolines
CN111093665A (zh)	2017-07-26	2020-05-01	细胞内治疗公司	有机化合物
EP3733204A4 (en)	2017-12-27	2021-09-15	Takeda Pharmaceutical Company Limited	THERAPEUTIC AGENT FOR URINARY INCONTINENCE OF STRESS AND FECAL INCONTINENCE
WO2019183341A1 (en)	2018-03-23	2019-09-26	Intra-Cellular Therapies, Inc.	Organic compounds
MX2020013116A (es)	2018-06-06	2021-05-12	Intra Cellular Therapies Inc	Sales y cristales novedosos.
WO2019237037A1 (en)	2018-06-08	2019-12-12	Intra-Cellular Therapies, Inc.	Novel methods
JP7483671B2 (ja)	2018-06-11	2024-05-15	イントラ－セルラー・セラピーズ・インコーポレイテッド	置換ヘテロ環縮合ガンマ－カルボリン類合成
US12144808B2 (en)	2018-08-29	2024-11-19	Intra-Cellular Therapies, Inc.	Compositions and methods
AU2019331490B2 (en)	2018-08-31	2025-04-24	Intra-Cellular Therapies, Inc.	Novel methods
JP7546546B2 (ja)	2018-08-31	2024-09-06	イントラ－セルラー・セラピーズ・インコーポレイテッド	新規方法
CA3121631A1 (en)	2018-12-17	2020-06-25	Intra-Cellular Therapies, Inc.	Substituted heterocycle fused gamma-carbolines synthesis
WO2020131911A1 (en)	2018-12-17	2020-06-25	Intra-Cellular Therapies, Inc.	Substituted heterocycle fused gamma-carbolines synthesis
CN113784962B (zh)	2019-02-27	2025-04-25	加利福尼亚大学董事会	用于治疗脑部疾病的氮杂环庚三烯并-吲哚类和其他杂环
EP4134101A1 (en)	2019-07-07	2023-02-15	Intra-Cellular Therapies, Inc.	Deuterated lumateperone for the treatment of the bipolar ii disorder
JP7261942B2 (ja)	2019-12-11	2023-04-20	イントラ－セルラー・セラピーズ・インコーポレイテッド	有機化合物
JP2025502614A (ja) *	2021-12-15	2025-01-28	デリックスセラピューティクス，インク．	縮合ピロリジンサイコプラストゲンとその使用
TW202333668A (zh)	2021-12-15	2023-09-01	美商德利克斯醫療公司	經苯氧基及苄氧基取代之精神成形素(psychoplastogen)及其用途
US12414948B2 (en)	2022-05-18	2025-09-16	Intra-Cellular Therapies, Inc.	Methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3839357A (en) *	1966-05-10	1974-10-01	Upjohn Co	1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles
US3676558A (en) *	1970-08-28	1972-07-11	Upjohn Co	Anorexigenic compositions comprising 6-alkyl-1,2,3,4,5,6-hexahydroazepino 4,5-indoles as active ingredient and process of treatment
EP0377238A1 (en) *	1988-12-22	1990-07-11	Duphar International Research B.V	New annelated indolo (3,2-c)-lactams

2000
- 2000-04-19 AR ARP000101881A patent/AR023574A1/es unknown
- 2000-04-19 PE PE2000000368A patent/PE20010052A1/es not_active Application Discontinuation
- 2000-04-20 ES ES00923532T patent/ES2226822T3/es not_active Expired - Lifetime
- 2000-04-20 HK HK02107016.3A patent/HK1045512B/zh not_active IP Right Cessation
- 2000-04-20 NZ NZ514553A patent/NZ514553A/en unknown
- 2000-04-20 BR BR0009983-0A patent/BR0009983A/pt not_active IP Right Cessation
- 2000-04-20 DK DK00923532T patent/DK1173440T3/da active
- 2000-04-20 AT AT00923532T patent/ATE276255T1/de not_active IP Right Cessation
- 2000-04-20 KR KR1020017013458A patent/KR20020005708A/ko not_active Ceased
- 2000-04-20 EP EP00923532A patent/EP1173440B1/en not_active Expired - Lifetime
- 2000-04-20 CN CNB008066639A patent/CN1183132C/zh not_active Expired - Fee Related
- 2000-04-20 SI SI200030516T patent/SI1173440T1/xx unknown
- 2000-04-20 AU AU43637/00A patent/AU760943C/en not_active Ceased
- 2000-04-20 WO PCT/US2000/010600 patent/WO2000064899A1/en not_active Ceased
- 2000-04-20 JP JP2000614251A patent/JP2002543080A/ja active Pending
- 2000-04-20 CA CA002367682A patent/CA2367682A1/en not_active Abandoned
- 2000-04-20 PT PT00923532T patent/PT1173440E/pt unknown
- 2000-04-20 DE DE60013803T patent/DE60013803T2/de not_active Expired - Fee Related
- 2000-04-27 EC EC2000003426A patent/ECSP003426A/es unknown
2001
- 2001-10-19 ZA ZA200108636A patent/ZA200108636B/en unknown

Also Published As

Publication number	Publication date
CA2367682A1 (en)	2000-11-02
AU760943C (en)	2003-12-04
NZ514553A (en)	2003-10-31
CN1183132C (zh)	2005-01-05
HK1045512A1 (en)	2004-10-15
EP1173440B1 (en)	2004-09-15
CN1348454A (zh)	2002-05-08
WO2000064899A1 (en)	2000-11-02
ATE276255T1 (de)	2004-10-15
BR0009983A (pt)	2002-04-16
ZA200108636B (en)	2003-02-19
HK1045512B (zh)	2005-09-02
PT1173440E (pt)	2004-12-31
DE60013803D1 (de)	2004-10-21
DE60013803T2 (de)	2005-11-17
EP1173440A1 (en)	2002-01-23
DK1173440T3 (da)	2004-12-20
AU760943B2 (en)	2003-05-22
ES2226822T3 (es)	2005-04-01
PE20010052A1 (es)	2001-01-27
AU4363700A (en)	2000-11-10
AR023574A1 (es)	2002-09-04
KR20020005708A (ko)	2002-01-17
JP2002543080A (ja)	2002-12-17
ECSP003426A (es)	2000-10-24

Publication	Publication Date	Title
SI1173440T1 (en)	2005-02-28	Tetracyclic azepinoindole compounds as 5-ht receptor ligands
AP2001002223A0 (en)	2001-09-30	Substituted bicyclic derivatives useful as anticancer agents
IL154310A0 (en)	2003-09-17	Heterocyclic compounds as ligands of the gabaa receptor
IL148119A0 (en)	2002-09-12	Novel spiro compounds
HUP0203375A3 (en)	2005-03-29	Substituted oxoazaheterocyclyl compounds
PL350095A1 (en)	2002-11-04	Ligands of melanocortinic receptors
GB2357761B (en)	2001-09-05	Compounds
ZA200200232B (en)	2003-04-10	Quinuclidine derivatives and their use as muscarinic M3 receptor ligands.
PL352911A1 (en)	2003-09-22	New compounds
AU1738900A (en)	2000-06-05	Serotonin ligands as pro-erectile compounds
PL356990A1 (en)	2004-07-12	Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
PL373953A1 (en)	2005-09-19	7-amino-benzothiazole derivatives as adenosine receptor ligands
EP1187607A4 (en)	2004-01-28	indole compounds
PL354360A1 (en)	2004-01-12	New compounds
EP1537110A4 (en)	2005-06-08	TRIAZOSPIRO COMPOUNDS WITH AFFINITY FOR THE RECEPTOR OF NOCICEPTIN
AU5319700A (en)	2000-12-18	Nicotine receptor ligands
HRP20020461A2 (en)	2004-04-30	Bridged metallocene compounds as olefin-polymerization catalysts
IL146151A0 (en)	2002-07-25	Human-g-protein receptor
AU2001259051A1 (en)	2001-11-26	Piperidyindoles as serotonin receptor ligands
AU3167402A (en)	2002-06-24	Aminotriazolopyridiine derivatives as adenosine receptor ligands
PL356140A1 (en)	2004-06-14	New compounds
EP1226140A4 (en)	2003-03-12	NEW INDOLIC COMPOUNDS
IL149007A0 (en)	2002-11-10	Pentacyclic taxane compounds
EP1187608A4 (en)	2004-02-25	INDOLE-BASED COMPOUNDS
AU4337599A (en)	1999-12-30	Substituted 1-aryl-3-benzylaminopyrrolidine: dopamine receptor subtype specific ligands